---
figid: PMC11120383__cancers-16-01831-g004
pmcid: PMC11120383
image_filename: PMC11120383__cancers-16-01831-g004.jpg
figure_link: /pmc/articles/PMC11120383/figure/F4/
number: Figure 4
figure_title: Timeline of milestones in targeted therapy with approval for treatment
  of advanced hepatocellular carcinoma.
caption: 'Timeline of milestones in targeted therapy with approval for treatment of
  advanced hepatocellular carcinoma. 1L: first-line; 2L: second-line; CPI: immune
  checkpoint inhibitor; TKI: tyrosine-kinase inhibitor; VEGF-mAb: monoclonal antibodies
  targeting the vascular endothelial growth factor pathway. * Approval withdrawn'
article_title: Insights in Molecular Therapies for Hepatocellular Carcinoma
citation: Philipp Heumann, et al. Cancers (Basel). 2024 May;16(10).
year: '2024'
pub_date: 2024-5-
epub_date: 2024-5-10
doi: 10.3390/cancers16101831
journal_title: Cancers
journa_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords:
- hepatocellular carcinoma
- targeted therapy
- molecular directed therapy
---
